News

Novo Nordisk Wins Legal Battle To Curb Unsafe Knockoff Versions Of Ozempic, Wegovy
The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...
Stocktwits on MSN1d
Novo Nordisk Wins Another Legal Battle Against Compounding Of Wegovy, Ozempic: Retail’s Bullish
Novo Nordisk (NVO) announced on Friday that it has secured a legal victory against compounders selling unauthorized versions ...
STAT1d
Court ruling opens door to FDA action against Ozempic compounders
Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...
Becker's Hospital Review2d
Drug approvals to watch in 2025
Health system pharmacists and physicians are monitoring a wave of expected new drug approvals between late 2024 and third quarter of 2025. A recent article published in the American Journal of ...
Zacks Investment Research on MSN2d
Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?
Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic ...